Neuraminidase (NA)

Neuraminidase (NA)

Neuraminidase (NA) Overview

Molecule Name
Neuraminidase
Synonyms
NA,Neuraminidase
Drug Development Progress
Drugs in Clinical Trials5
Approved Drugs4
Highest Development StageApproved
Target Synonym
Neuraminidase
Background
Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Neuraminidase (NA) Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
CD388CD-388; JNJ-0953; CD388Phase 3 ClinicalCidara Therapeutics Inc
Influenza, Human
Details
Peramivir Inhalation Solution (Langtian Medical Tech)Phase 2 ClinicalLangtian Medical Technology (Wuhan) Co Ltd
Influenza A virus infections; Influenza B virus infection
Details
Peramivir Inhalation Solution (广州南鑫药业)Phase 2 ClinicalGuangzhou Nanxin Pharma Co Ltd
Arthralgia; Cough; Fatigue; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Musculoskeletal Pain; Nasal Obstruction
Details
Oseltamivir/PimodivirPhase 1 ClinicalJohnson & Johnson
Influenza A virus infections
Details
Oseltamivir orally disintegrating tablets(Hefei Industrial Pharma)HY-100209Phase 1 ClinicalHefei Industrial Pharmaceutical Co Ltd
Influenza A virus infections; Influenza B virus infection
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Laninamivir Octanoate HydrateCS-8958; R-118958ApprovedDaiichi Sankyo Co LtdInavirJapanInfluenza B virus infection; Influenza A virus infections; Influenza, Humannull2010-09-10
Asthma; Influenza A virus infections; Influenza B virus infection; Influenza, Human
Details
ZanamivirGG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2enApprovedGlaxosmithkline Plc依乐韦, RelenzaUnited StatesInfluenza, HumanGlaxosmithkline Plc1999-07-26
Arthralgia; Dengue; Diabetes Mellitus, Type 2; Influenza, Human; Orthomyxoviridae Infections
Details
Oseltamivir PhosphateRo-64-0796; RO-640796; GS-4104; EN-241104; RO-640796/002; GS-4104/002; GS-4104-002ApprovedF. Hoffmann-La Roche Ltd, Gilead Sciences IncTamiflu, Hanmi Flu, 达菲SwitzerlandInfluenza, HumanF. Hoffmann-La Roche Ltd1999-09-21
Influenza A virus infections; Influenza in Birds; Influenza, Human; Kidney Failure, Chronic; Obesity; Purpura, Thrombocytopenic, Idiopathic
Details
Peramivir HydrateBCX-1812; JNJ-2; S-021812; RWJ-270201ApprovedBiocryst Pharmaceuticals IncPeramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu PremixJapanInfluenza, Humannull2010-01-13
Cough; Fatigue; Fever; Headache; Influenza A virus infections; Influenza B virus infection; Influenza, Human; Myalgia; Nasal Obstruction; Pharyngitis
Details